Trial Profile

A Phase 2 trial of TMP-301 in cocaine use disorder

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 26 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs HTL 0014242 (Primary)
Indications Cocaine-related disorders
Focus Adverse reactions; Therapeutic Use

Most Recent Events

26 Mar 2025 New trial record
25 Mar 2025 According to Nxera Pharma media release, Tempero Bio announced the close of a $70 million financing, the proceeds of which will be used to advance this study.
25 Mar 2025 According to Nxera Pharma media release, the study in cocaine use disorder planned to start over the next year

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com